No abstract

Aims: This study aimed at evaluating the effect of Algo-Bio® use on Escherichia coli resistance strains isolated from piglets intestinal flora. Study Design: Bacteriological study. Place and Duration of Study: Laboratory of the National Reference Center for antibiotics at Institute Pasteur Côte d’Ivoire, between March 2018 and June 2018. Methodology: A breeding of three batches of two piglets was carried out, then treatments with tetracycline and Algo-Bio® were administered to them. Enterobacteria was isolated on Mac Conkey medium added up with tetracycline and resistance rates were determined. Escherichia coli resistant strains have been identified and antibiotic susceptibility test was performed using disk diffusion method on Müller-Hinton agar. Results: Enterobacteria resistance rates increased ranging from 18.4% (D0) to 81.5% (D4) to tetracycline-treated piglets and respectively from 25.7% (D0) to 29% (D4) and from 22.3% (D0) to 24.5% (D4), in control piglets and those treated with Algo-Bio®. Antibiotic susceptibility test of Escherichia coli strains isolated from piglets treated with tetracycline showed high resistance to ceftazidime (83.3%), amoxicillin (76.9%) and tetracycline (92.3%) with 39.4% strains producing ESBL, 23.7% producing PHL and 5.2% of producing CHP on D4. Escherichia coli strains isolated from control piglets and Algo-Bio® treated piglets revealed a decrease of ESBL respectively from 17.6% (D0) to 13.7% (D4) and from 12.5% ​​(D0) to 6.4% (D4). Conclusion: The study showed that the use of Algo-Bio® does not induce an evolution of antimicrobial resistance in Microbiota strains and consequently this dietary supplement can be used as a good alternative to antibiotics.

Aim: The current study was aimed at evaluating the antibiotic resistance profile of Escherichia coli and Klebsiella spp isolated from post-weaned piglets treated with penicillin-streptomycin combination therapy. Study Design:  Bacteriological study. Place and Duration of Study: Laboratory of the National Reference Center for antibiotics at Institut Pasteur Côte d’Ivoire, between March 2018 and June 2018. Methodology: Escherichia coli and Klebsiella species were isolated from post weaned piglets stool on Mac Conkey medium added up separately with penicillin, streptomycin and combined penicillin-streptomycin and identified. Antibiotic susceptibility test was performed using disk diffusion method on Müller-Hinton agar. Results: Escherichia coli and Klebsiella species resistance to penicillin, streptomycin and combined penicillin-streptomycin evaluated, respectively, reached 80.5% (Day 0) to 92.0% (Day 4); 17.0% (Day 0) to 39.9% (Day 4) and 31.3% (Day 0) to 70.9% (Day 4) for piglets treated with Penstrep®. In addition, antibiotic susceptibility test carried out for Escherichia coli and Klebsiella spp strains isolated from piglets treated with Penstrep® revealed resistance to amoxicillin for each bacterial species at a rate of 86.0% and 89.0%. Furthermore, control piglets showed lesser resistance to streptomycin (E.coli 31.0% and Klebsiella spp 38.0%) than those treated with the combination therapy Penstrep® (E. coli 73.0% and Klebsiella spp 48.0%). As for netilmicin, imipenem and colistin, no resistance was detected for treated piglets as well as untreated ones. Conclusion: The combination therapy with Penstrep® has increased Escherichia coli and Klebsiella species resistance to antibiotics tested in the current study.

The consumption of food supplements such as Spirulina and Moringa is increasing in developing countries.However, these foods, due to certain processing conditions, are likely to be contaminated by moulds potentially producing dangerous mycotoxins. The objective of this study is to determine the level of contamination and the diversity of fungal flora found in Spirulina (Arthrospira platensis) and Moringa (Moringa oleifera) powder produced and marketed in Abidjan. A total of 360 samples of powder, including 144 of Spirulina and 216 of Moringa, were collected from different sales outlets. The identification of fungal isolates was carried out on the basis of classical mycology criteria. The prevalence of fungal strains in the analyzed products was 85.83%, which 77.99% in Spirulina and 22.01% in Moringa. The predominant species were Aspergillus flavus (24.6%), Aspergillus niger (21.68%), Penicillium sp (20.71%), and Aspergillus fumigatus (12.62%). The study shows that Spirulina powder and Moringa powder sold in markets are contaminated with moulds, some of which are potentially mycotoxin producers posing a health risk to consumers. Strict hygiene measures must be observed during the production and marketing of Moringa and Spirulina powders in order to prevent any poisoning among consumers.